Heat Processing Reduces IgE Binding but Not Basophil Sensitivity to Pea Proteins in Pea-Allergic Children. [PDF]
Teodorowicz M +5 more
europepmc +1 more source
Near-Field Channel Parameter Estimation and Localization for mmWave Massive MIMO-OFDM ISAC Systems via Tensor Analysis. [PDF]
Jiang L, Guan J, Du J, Jiang W, Cheng Y.
europepmc +1 more source
Terahertz integrated sensing and mobile communications empowered by a 220-GHz-band portable device. [PDF]
Wang G +8 more
europepmc +1 more source
Marker-to-Object Calibration Using Landmark Touch. [PDF]
Ai L, Sengupta S, Chen Y.
europepmc +1 more source
Hypergravity Enhances Stretch Sensitivity in Rat Cardiomyocytes via Increased Expression and Activity of Stretch-Activated Channels. [PDF]
Kamkin AG +8 more
europepmc +1 more source
Socio-demographic factors influencing obesity among ever-married Jordanian women of reproductive age: insights from the 2023 Jordan demographic and health survey. [PDF]
Ibrahim AAA +4 more
europepmc +1 more source
Related searches:
ISAC-II : a project for higher energies at ISAC
PACS2001. Proceedings of the 2001 Particle Accelerator Conference (Cat. No.01CH37268), 2015In the field of nuclear physics it is generally acknowledged that a new frontier will be probed when radioactive ion beams of sufficient intensity and quality become available. With the ISAC facility, TRIUMF has positioned itself as offering the best possible source of exotic beams in the world for many years to come.
TRIUMF-ISAC Facility, Towner, I.
+5 more sources
TRIUMF operates the rare ion beam facility ISAC, which provides intense beams of short lived isotopes in the energy range from 0.15 to 5 A MeV for A < 30 to a full suite of world class experimental apparatus, enabling a forefront research program focused on understanding the evolution of nuclear structure towards the limits of existence, the origin of ...
J. Dilling, R. Krücken, G. Ball
openaire +1 more source
The TRIUMF-ISAC radioactive ion beam facility was designed and constructed to allow irradiation of thick targets with up to 100 \(\upmu \)A proton beam intensities. Since beginning operation in 1998, beam intensities on ISAC targets have progressively increased toward the 100 \(\upmu \)A design limit.
M. Dombsky, P. Kunz
openaire +1 more source
Immunostimulatory agents such as Toll-like receptor (TLR) agonists have shown promising antitumor efficacy but are associated with therapy-related toxicities when delivered systemically. Immune-stimulating antibody conjugates are now shown to deliver TLR agonists with potent preclinical antitumor activities.
Demaria, Olivier, Vivier, Eric
openaire +3 more sources

